Minimally invasive procedures: Advances in image-guided delivery of drug and cell therapies into the central nervous system

Neuroimaging Clinics of North America

Volumn 11, Issue 4, 2001, Pages 727-735

  Broaddus, William C ^a   Gillies, George T ^a   Kucharczyk, John ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARMUSTINE; FLOXURIDINE; IODINE 131; MONOCLONAL ANTIBODY; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; PENTETATE INDIUM IN 111;

BLOOD BRAIN BARRIER; BRAIN TUMOR; CATHETER; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DRUG DELIVERY SYSTEM; GENE THERAPY; HUMAN; MINIMALLY INVASIVE SURGERY; NEUROSURGERY; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

BRAIN NEOPLASMS; DRUG DELIVERY SYSTEMS; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; SURGERY, COMPUTER-ASSISTED; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TISSUE THERAPY;

EID: 0035712028     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Convection-enhanced delivery of AAV vector in parkinsonian monkeys: In vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach
2. A study of the apparent diffusion coefficient of grey and white matter in human ischaemic stroke
3. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis
4. Transplantation options for therapeutic central nervous system remyelination
5. Convectionenhanced delivery of macromolecules in the brain
6. Implantation of fetal tissue for the management of Parkinson's disease: A technical note
7. Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion
8. Strategies for the design and delivery of antisense oligonucleotide in the central nervous system: Methods of enzymology
9. Variables affecting convection-enhanced delivery to the striatum: A systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time
10. Development of fetal neural transplantation as a treatment for Parkinson's disease
11. Extended local access fibers: Adjustable treatment of deep sites in the brain
12. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease
13. Fatal transplant cyst
14. Experimental study of the magnetic stereotaxis system for catheter manipulation within the brain
15. Magnetically guided stereotaxis
16. Neural transplantation of hNT neurons for Huntington's disease
17. Microinjections of dopaminergic agents in the nucleus accumbens affect ethanol consumption but not palatability
18. Transplantation of cultured human neuronal cells for patients with stroke
19. Fetal transplantation for the treatment of neurodegenerative diseases: Current status and future potential
20. Safety of intrastriatal neurotransplantation for Huntington's disease patients
21. Tumor regression with regional distribution of the targeted toxin TF-CRM 107 in patients with malignant brain tumors
22. Convection-enhanced selective excitotoxic ablation of the neurons of the globus pallidus internus for treatment of parkinsonism in nonhuman primates
23. Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson's disease
24. Neural transplantation cannula and microinjector system: Experimental and clinical experience
25. 3-octreotide (DOTATOC): A pilot study in human gliomas
26. 111In-labelled SCN-bz-DTPA-BC-2 MAb following locoregional injection into glioblastomas
27. High-flow microinfusion: Tissue penetration and pharmacodynamics
28. Gene therapy for the treatment of brain tumors using intratumoral transduction with the thymidine kinase gene and intravenous ganciclovir
29. Immunotoxins for brain tumor therapy
30. 131In monoclonal antibody: Feasibility, pharmacokinetics, and dosimetry
31. The future of drug infusion into the brain
32. Determination of intracranial tumor volumes in a rodent brain using magnetic resonance imaging, Evans blue, and histology: A comparative study
33. Multicolumn infusion of gene therapy cells into human brain tumors: Technical report
34. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
35. Intratumoral administration of recombinant circularly permuted interleukin-4 pseudomanos exotoxin in patients with high-grade glioma
36. Positron emission tomography, a new clinical research tool: The example of neuronal grafts in Parkinson's disease
37. 131In: Comparison of the results obtained in recurrent and newly diagnosed tumors
38. Loss of connectivity in Alzheimer's disease: An evaluation of white matter tract integrity with colour-coded MR diffusion tensor imaging
39. Restorative neurosurgery: Opportunities for restoration of function in acquired, degenerative, and idiopathic neurological diseases
40. Intratumoral chemotherapy